A detailed history of Seven Eight Capital, LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 96,934 shares of DYN stock, worth $2.32 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
96,934
Previous 53,739 80.38%
Holding current value
$2.32 Million
Previous $1.9 Million 83.6%
% of portfolio
0.33%
Previous 0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$31.94 - $47.04 $1.38 Million - $2.03 Million
43,195 Added 80.38%
96,934 $3.48 Million
Q2 2024

Aug 12, 2024

BUY
$23.65 - $35.63 $841,183 - $1.27 Million
35,568 Added 195.74%
53,739 $1.9 Million
Q1 2024

May 13, 2024

BUY
$13.06 - $29.18 $237,313 - $530,229
18,171 New
18,171 $515,000

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.